" class="no-js "lang="en-US"> NYU Langone Health Archives - Medtech Alert
Monday, May 19, 2025

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

NYU Langone Health and Deerfield Management Launch Amethyst Innovations with Up To $130 Million to Accelerate Commercialization of Biomedical Discoveries

NYU Langone Health and Deerfield Management Company, a healthcare investment firm, today announced the launch […]

Researchers Reveal Newfound DNA Repair Mechanism

A new study adds to an emerging, radically new picture of how bacterial cells continually […]

Plugging Immune Cell Leakage from Tumors Could Improve Skin Cancer Treatment

The number of specialized immune cells available for fighting skin cancer doubled when a new […]

Fluent BioSciences Launches Industry's Most Accessible, Cost-effective and Scalable Technology (PIPseq™) to Accelerate Adoption of Single-cell RNA Sequencing in Any Laboratory

Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every […]

Largest Clinical Study Validating A Blood-based Colorectal Screening Test Completes Enrollment

Freenome, a privately held biotech company, announced the completion of enrollment for PREEMPT CRC, the […]

Structure of a Bacterial "Drug Pump" Reveals New Way to Counter Hospital-borne Infection

By revealing the structure of a protein used by bacteria to pump out antibiotics, a […]

Researchers Discover New Model for "Global" DNA Repair

Two studies provide a radically new picture of how bacterial cells continually repair damaged sections […]

NYU Langone Health Launches Parekh Center for Interdisciplinary Neurology to Accelerate Scientific Discovery

NYU Langone Health announced today the launch of the Parekh Center for Interdisciplinary Neurology, made possible […]

Artificial Intelligence Tool Improves Accuracy of Breast Cancer Imaging

A computer program trained to see patterns among thousands of breast ultrasound images can aid […]

FDA Clears NYU Langone Genome PACT

The U.S. Food and Drug Administration (FDA) has cleared for clinical lab use a gene […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more